Cedar Capital’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-8,595
| Closed | -$3.8M | – | 160 |
|
|
2020
Q3 | $3.8M | Buy |
8,595
+2,708
| +46% | +$1.2M | 1.26% | 24 |
|
|
2020
Q2 | $2.13M | Buy |
5,887
+202
| +4% | +$73.2K | 0.82% | 44 |
|
|
2020
Q1 | $1.61M | Sell |
5,685
-513
| -8% | -$145K | 0.76% | 38 |
|
|
2019
Q4 | $2.01M | Buy |
6,198
+1,223
| +25% | +$397K | 0.93% | 24 |
|
|
2019
Q3 | $1.45M | Buy |
4,975
+875
| +21% | +$255K | 0.68% | 42 |
|
|
2019
Q2 | $1.2M | Sell |
4,100
-149
| -4% | -$43.8K | 0.51% | 47 |
|
|
2019
Q1 | $1.16M | Sell |
4,249
-103
| -2% | -$28.2K | 0.51% | 48 |
|
|
2018
Q4 | $974K | Sell |
4,352
-997
| -19% | -$223K | 0.49% | 52 |
|
|
2018
Q3 | $1.31M | Buy |
5,349
+1,542
| +41% | +$376K | 0.51% | 47 |
|
|
2018
Q2 | $789K | Buy |
3,807
+1,050
| +38% | +$218K | 0.35% | 61 |
|
|
2018
Q1 | $569K | Buy |
2,757
+947
| +52% | +$195K | 0.27% | 69 |
|
|
2017
Q4 | $344K | Buy |
1,810
+429
| +31% | +$81.5K | 0.17% | 91 |
|
|
2017
Q3 | $261K | Buy |
1,381
+65
| +5% | +$12.3K | 0.12% | 96 |
|
|
2017
Q2 | $230K | Buy |
+1,316
| New | +$230K | 0.1% | 101 |
|
|
2016
Q4 | – | Sell |
-1,372
| Closed | -$218K | – | 100 |
|
|
2016
Q3 | $218K | Sell |
1,372
-293
| -18% | -$46.6K | 0.08% | 85 |
|
|
2016
Q2 | $246K | Sell |
1,665
-14
| -0.8% | -$2.07K | 0.08% | 73 |
|
|
2016
Q1 | $238K | Sell |
1,679
-178
| -10% | -$25.2K | 0.07% | 64 |
|
|
2015
Q4 | $263K | Buy |
+1,857
| New | +$263K | 0.06% | 63 |
|